These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 8017432
21. Dornase alfa for cystic fibrosis. Yang CL, Chilvers M, Montgomery M, Nolan SJ. Paediatr Respir Rev; 2017 Jan; 21():65-67. PubMed ID: 27769785 [No Abstract] [Full Text] [Related]
22. Dornase alfa for cystic fibrosis. Robert G, Stevens A, Colin-Jones D. BMJ; 1995 Sep 23; 311(7008):813. PubMed ID: 7580474 [No Abstract] [Full Text] [Related]
23. Dornase alfa for cystic fibrosis. Evidence supporting use of this drug has not yet been published. Collier J. BMJ; 1995 Jun 10; 310(6993):1533-4. PubMed ID: 7787616 [No Abstract] [Full Text] [Related]
33. Dornase alfa is well tolerated: data from the epidemiologic registry of cystic fibrosis. McKenzie SG, Chowdhury S, Strandvik B, Hodson ME, Investigators of the Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol; 2007 Oct 10; 42(10):928-37. PubMed ID: 17726701 [Abstract] [Full Text] [Related]
34. The use of recombinant human dornase alfa in CF. Cox C. Paediatr Nurs; 1995 Nov 10; 7(9):29-31. PubMed ID: 8705343 [No Abstract] [Full Text] [Related]
35. Does the timing of inhaled dornase alfa matter? van der Giessen L. J Cyst Fibros; 2009 Jun 10; 8 Suppl 1():S6-9. PubMed ID: 19460684 [Abstract] [Full Text] [Related]
39. Evaluation of Inhaled Dornase Alfa Administration in Non-Cystic Fibrosis Patients at a Tertiary Academic Medical Center. Torbic H, Hacobian G. J Pharm Pract; 2016 Oct 10; 29(5):480-3. PubMed ID: 25667210 [Abstract] [Full Text] [Related]
40. Randomized trial of efficacy and safety of dornase alfa delivered by eRapid nebulizer in cystic fibrosis patients. Sawicki GS, Chou W, Raimundo K, Trzaskoma B, Konstan MW. J Cyst Fibros; 2015 Nov 10; 14(6):777-83. PubMed ID: 25921451 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]